Categories: HealthcareNews

DLH to Announce Fiscal 2023 Fourth Quarter Financial Results

ATLANTA, Nov. 27, 2023 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for its fiscal fourth quarter ended September 30, 2023 on December 6, 2023 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, December 7, 2023, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow. 

Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.  Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call. A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 4720443.

About DLH
DLH (NASDAQ:DLHC) delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 3,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit http://www.DLHcorp.com.

INVESTOR RELATIONS
Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com

 

Staff

Recent Posts

Xediton Pharmaceuticals Inc. To Present at The 2024 Bloom Burton & Co. Healthcare Investor Conference

Oakville, Ontario--(Newsfile Corp. - April 9, 2024) - Xediton Pharmaceuticals Inc., a leading Canadian specialty…

38 mins ago

Emet Surgical Accepted into Innosphere Ventures Life Sciences Incubator Program

DENVER--(BUSINESS WIRE)--Emet Surgical, developers of innovative tools to improve surgery outcomes, today announced its acceptance…

2 hours ago

Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Edmonton, Alberta--(Newsfile Corp. - April 9, 2024) - Entos Pharmaceuticals, (Entos), a genetic medicines company…

2 hours ago

Chadwick Robertson, Pharmacist, Highlighted for Pioneering Renewable Energy in Healthcare Facilities

VANCOUVER, BC / ACCESSWIRE / April 9, 2024 / In a brand new online article…

2 hours ago

My Quest Story – Jessica Clow

NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 / Quest Diagnostics:I began working at Quest…

2 hours ago

Transforming Healthcare with Generative AI and LLMs: Insights from Industry Leaders Webinar

Listen to full webinar here HOSTED BY Ben MaisanoSVP, Head of Strategy, Tendo. Formerly of…

3 hours ago